1.Tanaka N, Doi K, Mieno M. Multiple Time Scale in Survival and Time-to-Event Analysis. The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region. January 2026.
2.Mieno M, Tanaka N, Doi K, Ishikawa S. Impact of the Choice of Primary Time Scale on the Estimated Effect of Smoking in Survival Analysis. The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region. January 2026.
3.Ogura M, Yamaki J, Homma MK. Succinate dehydrogenase activity is regulated by phosphorylation via CK2 in nucleus. The 99th Annual Meeting of the Japanese Pharmacological Society. March 2026.
2025
1.Hitomi Y, Aiba Y, Ishigaki K, Nakamura M. CXCR5 regulates disease susceptibility and activity in primary biliary cholangitis. The 54th Annual Meeting of the Japanese Society for Immunology. December 2025.
2.Hitomi Y, Aiba Y, Ueno K, Takahashi H, Kono M, Nishida N, Kawai Y, Kawashima M, Khor SS, Yasunami M, Ishigaki K, Nagasaki M, Tokunaga K, Nakamura M. Effect of CXCR5-positive B cells on disease susceptibility and activity in primary biliary cholangitis. The 70th Annual Meeting of the Japan Society of Human Genetics. December 2025.
3.Ishizaka Y, Takashina T, Kido J, Hitomi Y, Miyake N, Matsumoto S, Nakamura K. A protein-based engineering of human fibroblast-derived hepatic progenitors applicable for a gene-cell therapy to tyrosinemia type-1. The 15th International Congress of Inborn Errors of Metabolism. September 2025.
4.Ogura M. Suppression of inflammatory microglia by the immunosuppressive agent PQA-18, a prenylquinoline carboxylic acid derivative. 2025 Annual Meeting of the Institute of Prophylactic Pharmacology. September 2025.
Publications
2026
1.Shimada M, Omae Y, Hitomi Y, Honda Y, Kodama T, Honda M, Tokunaga K, Miyagawa T. DNA methylation and multi-omics profiling of T cells uncovers chemotactic pathways and proliferation-linked hypomethylation in narcolepsy type 1. Sleep (in press)
2025
1.Aizawa M, Suzuki K, Nakajima Y, Utano K, Tamazawa K, Ueda K, Wada J, Sato K, Shibukawa G, Tanaka N, Togashi K. Therapeutic Agents and Patient Characteristics Affecting Metabolism of Thiopurines in Patients with Inflammatory Bowel Disease. Fukushima J Med Sci. 2025. 71(1):47-55.
2.Tanaka N. Introduction to biostatistics ─Its history and contribution to medical science─. Major Histocompatibility Complex. 2025. 32(2):68-79. (In Japanese)
3.Muto S, Homma MK, Kiko,Y, Ozaki Y, Watanabe M, Okabe N, Hamada K, Hashimoto Y, Suzuki H. Nucleolar CK2a as a prognostic factor in patients with surgically resected early-stage lung adenocarcinoma. Oncology Reports. 2025. 53(4):1-9.
